Usted buscó: sjs (Inglés - Maltés)

sjs, ten, erythema multiforme
sjs, ten, eritema multiforme

sjs and ten have been reported.
sjs u ten kienu rrappurtati.

fatal cases of sjs, ten and hypersensitivity reactions have been reported.
Ġew rapportati wkoll każijiet fatali ta ’ sjs, ten u reazzjonijiet ta 'ipersensittività.

clofarabine must be discontinued for exfoliative or bullous rash, or if sjs or ten is suspected.
clofarabine għandu jitwaqqaf għal raxx li jinvolvi tqaxxir jew infafet, jew jekk ikun hemm suspett ta’ sjs jew ten.

fatal cases of sjs, ten and drug reaction with eosinophilia and systemic symptoms have been reported.
Ġew irrapportati wkoll każijiet fatali ta’ sjs, ten u reazzjoni minħabba l-mediċina b’esinofilja u sintomi sistemiċi reazzjonijiet ipersensittivi.

if the patient has developed sjs or dress associated with the use of evotaz, evotaz may not be restarted.
jekk il-pazjent ikun żviluppa sjs jew dress assoċjati mal-użu ta’ evotaz, evotaz ma jistax jerġa’ jibda jingħata.

however, absence of these alleles upon genotyping does not exclude that sjs/ten can still occur.
madankollu, in-nuqqas ta’ dawn l-alleli mal-ġenotipar ma jeskludix li sjs/ten xorta jista’ jseħħ.

if the patient has developed sjs, ten or dress with the use of osseor, osseor must not be re-started.
jekk il-pazjent ikun żviluppa sjs, ten jew dress bl-użu ta’ osseor, osseor ma għandux jerġa’ jingħata

all three cases included concomitant medications which list sjs and toxic epidermal necrolysis (ten) as adverse events in the smpc.
it-tliet każijiet kollha kienu jinkludu mediċini li jingħataw fl-istess ħin, li jelenkaw sjs u nekrolisi tossika epidermali (ten, toxic epidermal necrolysis) bħala avvenimenti avversi fl-smpc.

25 the first 18 weeks of therapy with viramune are a critical period which requires close monitoring of patients to disclose the potential appearance of severe and life-threatening skin reactions (including cases of stevens-johnson syndrome (sjs) and toxic epidermal necrolysis (ten)) or serious hepatitis/ hepatic failure.
27 l- ewwel 18- il ġimgħa ta 'trattament b’ viramune huwa perijodu kritiku li jeħtieġ monitoraġġ mill- viċin biex jinkixfu sinjali li jistgħu jintwerew f’ każijiet ta ’ reazzjonijiet qawwija fil- ġilda li jistgħu jwasslu sal- mewt (li jinkludu każijiet ta' sindromu stevens- johnson (sjs) u nekroliżi tossika epidermali (ten)) jew każijiet ta ’ epatite serja / insuffiċjenza tal- fwied.